D-1085-2023 Class III Terminated
FDA drug recall D-1085-2023 was initiated by Advanced Accelerator Applications USA, Inc. on Aug 7, 2023 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date: vials were labeled with the incorrect lot number and expiration date The recall status is terminated (terminated Mar 12, 2024). Affected quantity: 10.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 23, 2023
- Initiation Date
- Aug 7, 2023
- Termination Date
- Mar 12, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10
Product description
PLUVICTO 1,000MBq/mL (27 mCi/mL), lutetium Lu 177 vipivotide tetraxetan injection, 9.2 mL Single-dose vial, Manufacturer: Advanced Accelerator Appllications USA, Inc., 57 E. Willow Street NJ 07041, Milburn, USA, NDC 69488-010-61
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date: vials were labeled with the incorrect lot number and expiration date
Distribution pattern
Distributed Nationwide in the USA
Code information
Lot # LPS230729B-16, Exp 8/3/2023 at 10:00am, LPS230804B-16, Exp 8/9/2023 at 10:00am.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1085-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026